Fortrea Holdings (FTRE) Cash from Financing Activities (2022 - 2025)

Fortrea Holdings (FTRE) posted Cash from Financing Activities of -$75.7 million for Q4 2025, down 51.4% on a QoQ basis from -$50.0 million in Q3 2025, and down 6781.82% year-over-year from $1.1 million in Q4 2024.

Fortrea Holdings (FTRE) Cash from Financing Activities (2022 - 2025) Analysis & Trends

Fortrea Holdings' Cash from Financing Activities history runs 4 years deep, the most recent figure standing at -$75.7 million for Q4 2025.

  • Quarterly Cash from Financing Activities fell 6781.82% year-over-year to -$75.7 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$164.7 million (up 61.76% YoY) and the FY2025 annual result came in at -$76.3 million, up 84.67% from the prior year.
  • Cash from Financing Activities was -$75.7 million for Q4 2025 at Fortrea Holdings, down from -$50.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $88.4 million in Q1 2025 and bottomed at -$504.0 million in Q2 2024.
  • A 4-year average of -$54.8 million and a median of -$10.8 million in 2023 frame the typical range for Cash from Financing Activities.
  • Peak annual rise in Cash from Financing Activities reached 315.02% in 2025, while the deepest fall reached 6781.82% in 2025.
  • Fortrea Holdings' Cash from Financing Activities stood at -$5.9 million in 2022, then sank by 30.51% to -$7.7 million in 2023, then soared by 85.71% to -$1.1 million in 2024, then sank by 6781.82% to -$75.7 million in 2025.
  • Business Quant data shows FTRE's Cash from Financing Activities at -$75.7 million in Q4 2025, -$50.0 million in Q3 2025, and -$39.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Fortrea Holdings 1.83 Bn 1.68 Bn 123.60 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -75.70 Mn
Dec 31, 2025 -75.70 Mn
Sep 30, 2025 -50.00 Mn
Sep 30, 2025 -50.00 Mn
Jun 30, 2025 -39.00 Mn
Jun 30, 2025 -39.00 Mn
Mar 31, 2025 88.40 Mn
Mar 31, 2025 88.40 Mn
Dec 31, 2024 -1.10 Mn
Dec 31, 2024 -1.10 Mn
Sep 30, 2024 -14.00 Mn
Sep 30, 2024 -14.00 Mn
Jun 30, 2024 -504.00 Mn
Jun 30, 2024 -504.00 Mn
Mar 31, 2024 21.30 Mn
Mar 31, 2024 21.30 Mn
Dec 31, 2023 -7.70 Mn
Dec 31, 2023 -7.70 Mn
Sep 30, 2023 -7.70 Mn
Sep 30, 2023 -7.70 Mn